Rhabdomyosarcoma after puberty. Clinical, tissue culture and immunological studies.
D000293:Adolescent; D000328:Adult; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D002460:Cell Line; D002478:Cells, Cultured; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007114:Immunization; D008297:Male; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal; D009858:Oncogenic Viruses / Q000276:immunology; D012008:Recurrence; D012075:Remission, Spontaneous; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D014750:Vincristine / Q000627:therapeutic use
D000951:Antigens, Neoplasm; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide